Buy or sell Emergex Vaccines stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Emergex Vaccines Stock

Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.



Notable Investors

Vickers Venture Partners


Abingdon, GB

Total Funding


About Emergex Vaccines Stock

Emergex Vaccines offer affordable, practical and effective vaccines on-demand, which are suited to low resource environments, disproportionately affected by pandemics. These vaccines will be used to create a clinical grade international vaccine repository that will act as a first line of defence in the case of existing and newly emerging infectious disease outbreaks.


Vickers Venture Partners

Biosplice Therapeutics, Emergex Vaccines

Funding History

May 2018$979K
January 2020$11.0M
February 2022$491K


Founder and CEO

Thomas Rademacher

Founder, Executive Director, Chief Operating Officer

Storme Moore-Thornicroft

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: